AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 273 min read$LRCX

Lam Research Stock Is 45% Below Its High. How Deep Have Past Drops Gone?

Lam Research (LRCX) shares have fallen 45.1% from their June 30 high, despite reporting record revenue. Historically, the stock has declined more than the S&P 500 during market shocks, with an average drop of 22.8%. The company's operating margin is at a 40-quarter high, and it holds $7.44 billion in cash. Management cited supply chain constraints for a cautious revenue forecast.

Original reporting
finance.yahoo.com
Published Oct 27, 2026, 4:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 5:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Lam Research Stock Is 45% Below Its High. How Deep Have Past Drops Gone? — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$LRCXNeutralMed
01

Why it matters

Earnings and guidance provide fresh data for valuation models; investors will reassess price targets based on margin strength versus guidance shortfall.

02

Market read

The earnings release offers new quantitative insight into Lam Research's performance and outlook, influencing both sector sentiment and individual stock positioning.

03

What to watch

Long‑term memory‑segment demand may accelerate, offsetting short‑term supply constraints.

Relevance 7/10Novelty 7/10Timing: post‑market Oct 26

Background

Lam Research posted its fifth consecutive quarter of record revenue, driven by memory‑segment growth, while noting supply‑chain constraints that could affect upcoming quarters.

Company-level read

Ticker impact

$LRCXNeutralHigh confidence
Context

The article reports Lam Research's Q1 2027 earnings with record revenue and provides fresh guidance for the December quarter.

Expected impact

potential modest downside as investors price in near‑term supply‑chain pressure

Evidence & confidence

Record sales and high margins support the stock, but guidance below consensus and noted constraints may limit upside.

Market effects

Sector

Highlights resilience of semiconductor equipment sector despite macro headwinds.

Regional

U.S. tech stocks may see slight pullback as guidance tempers optimism.

Global

Signals potential supply‑chain bottlenecks for global chip manufacturers.

Counterpoint

What could challenge this read

The strong margin expansion could outweigh guidance concerns, supporting a rally.

Key entities

  • Company
    Lam Research

    Semiconductor equipment maker reporting Q1 2027 results.

Read at source← All news

Related articles

OCT 27
$LRCXMedAI 8/10

Tech Sell-Off: This All-Star Artificial Intelligence Stock Is Down 50% but Up 127,300% Since Its IPO. Here's Why It's a Screaming Buy Heading Into the Midterms.

Lam Research (LRCX) stock is down 50% from its June high but up 127,300% since its 1984 IPO. The semiconductor equipment maker reported record Q3 revenue of $8.22B and EPS of $2.20, beating estimates. Despite strong results, the stock fell due to 'light' guidance of $8.6B revenue and $2.33 EPS for Q4, attributed to supply constraints. Management forecasts industrywide wafer front-end equipment spending to exceed $200B by 2027, with Lam expected to grow faster than the industry.

finance.yahoo.com3 min
OCT 26
$LRCXMed

Lam Research Stocks Gain 4.3% Despite Citi's Target Cut

Lam Research (LRCX) shares rose 4.3% to $239.93 on October 26, despite Citi cutting its price target while maintaining a Buy rating. The company projected December-quarter revenue of $8.6 billion, with a 40.2% adjusted operating margin in September. Investors will watch for earnings growth to meet expectations.

finance.yahoo.com2 min
OCT 25
$METAMedAI 8/10

Does enough capital exist to finance everyone’s ambitious AI spending plans?

Meta reported a 26% revenue increase to $64.6B, but negative free cash flow of -$2.1B. The company raised its 2026 capital spending forecast to $135B-$145B and announced new non-voting shares. Executives from Broadcom, BlackRock, and Nvidia expressed concerns about capital scarcity for AI development. AI-linked stocks like Nvidia, CoreWeave, and Lam Research fell, while broader market indices showed mixed performance. Treasury yields also declined.

investing.com3 min
OCT 24
$AAPLMed

5 big analyst AI moves: ’Uniquely catalyst-rich’ months ahead for SpaceX

Loop Capital downgraded Apple to Hold, cutting its price target to $330 and lowering iPhone revenue forecasts. JPMorgan upgraded Intel to Neutral, citing balanced risk-reward. Citi initiated a positive Catalyst Watch on SpaceX, highlighting upcoming catalysts. Mizuho reiterated Outperform on Lam Research, recommending buying on pullback. Yardeni Research noted an AI bubble but said it's not yet close to bursting.

investing.com3 min
OCT 24
$LRCXHighAI 8/10

The Pareto Investor (@paretoinvestor)

Lam Research reported record revenue of $8.22B, beating estimates, but its CFO cited supply chain constraints for lower-than-expected guidance. Shares fell 11%, and other chip-related stocks like Nvidia, Qualcomm, Marvell, Intel, Applied Materials, and ASML also declined. The downturn reflects broader chip sector volatility and supply chain concerns.

substack.com2 min
OCT 24
$LRCXMed

Lam Says U.S. Export Rules Limit China Revenue as Share Rebounds to 35%

Lam Research reported that U.S. export rules have reduced its China revenue, which accounted for 35% of its $8.27 billion in sales for the quarter ended Sept. 27. This is up from 26% in June but down from 43% in the same period last year. The company warned that the impact of these rules could increase, affecting its future revenue. Lam projected revenue of $8.6 billion for the next quarter.

econotimes.com2 min